Detalhe da pesquisa
1.
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Oncologist
; 29(2): e266-e274, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715957
2.
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives.
Curr Opin Oncol
; 35(6): 507-512, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621167
3.
New Concepts in Cardio-Oncology.
Cancer Treat Res
; 188: 303-341, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175351
4.
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer.
Curr Opin Oncol
; 34(6): 595-605, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083118
5.
Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?
Lancet Oncol
; 23(3): 325-328, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240079
6.
Biomarkers for Antibody-Drug Conjugates in Solid Tumors.
Mol Cancer Ther
; 23(4): 436-446, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363729
7.
Cardiotoxicity of Agents Used in Patients With Breast Cancer.
JCO Oncol Pract
; 20(1): 38-46, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983586
8.
Targeting HER2 heterogeneity in breast and gastrointestinal cancers.
Trends Cancer
; 10(2): 113-123, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008666
9.
Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response.
J Clin Oncol
; : JCO2301935, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569132
10.
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.
Eur J Cancer
; 196: 113423, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977104
11.
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer.
Cancer Treat Rev
; 128: 102761, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772169
12.
Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges.
Cancers (Basel)
; 15(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831473
13.
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives.
Ther Adv Med Oncol
; 15: 17588359221146129, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743524
14.
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.
Cancers (Basel)
; 15(3)2023 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765724
15.
The immunogram of inflammatory breast cancer.
Cancer Treat Rev
; 119: 102598, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437342
16.
Treatment optimization in early triple negative breast cancer.
Expert Rev Anticancer Ther
; 23(10): 1107-1116, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37873652
17.
Variant allele frequency: a decision-making tool in precision oncology?
Trends Cancer
; 9(12): 1058-1068, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704501
18.
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Endocr Relat Cancer
; 30(10)2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428640
19.
Serological response after anti-SARS-CoV-2 BNT162b2 vaccine in IBD patients on biological therapy: a monocentric case-control study.
Minerva Gastroenterol (Torino)
; 69(2): 268-276, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255283
20.
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments.
Eur J Cancer
; 190: 112944, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437366